Price
$35.91
Increased by +7.94%
Dollar volume (20D)
43.32 M
ADR%
5.13
Earnings report date
Feb 19, 2025
Shares float
65.11 M
Shares short
6.92 M [10.63%]
Shares outstanding
65.68 M
Market cap
2.19 B
Beta
1.37
Price/earnings
N/A
20D range
29.48 36.30
50D range
27.15 38.94
200D range
27.15 53.69

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.

The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system.

It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body.

In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data.

The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008.

Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 6, 24 -0.35
Increased by +7.89%
-0.40
Increased by +12.50%
Aug 1, 24 -0.48
Increased by +12.73%
-0.54
Increased by +11.11%
May 2, 24 -0.63
Increased by +67.19%
-0.76
Increased by +17.11%
Feb 21, 24 -0.27
Decreased by -8.00%
-0.25
Decreased by -8.00%
Nov 1, 23 -0.38
Decreased by -40.74%
-0.34
Decreased by -11.76%
Aug 3, 23 -0.55
Decreased by -129.17%
-0.53
Decreased by -3.77%
May 3, 23 -1.92
Decreased by -734.78%
-0.52
Decreased by -269.23%
Feb 22, 23 -0.25
Decreased by -256.25%
-0.06
Decreased by -316.67%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 24 363.29 M
Increased by +95.71%
-23.25 M
Increased by +29.46%
Decreased by -6.40%
Increased by +63.96%
Jun 30, 24 221.91 M
Increased by +13.27%
-30.81 M
Increased by +13.87%
Decreased by -13.89%
Increased by +23.96%
Mar 31, 24 191.67 M
Increased by +13.16%
-42.72 M
Increased by +65.52%
Decreased by -22.29%
Increased by +69.53%
Dec 31, 23 196.80 M
Decreased by -10.75%
-30.00 M
Decreased by -89.26%
Decreased by -15.25%
Decreased by -112.06%
Sep 30, 23 185.62 M
Decreased by -9.25%
-32.96 M
Increased by +32.69%
Decreased by -17.76%
Increased by +25.83%
Jun 30, 23 195.92 M
Decreased by -2.17%
-35.77 M
Decreased by -137.61%
Decreased by -18.26%
Decreased by -142.88%
Mar 31, 23 169.38 M
Decreased by -3.71%
-123.87 M
Decreased by -741.81%
Decreased by -73.13%
Decreased by -774.24%
Dec 31, 22 220.50 M
Increased by +5.00%
-15.85 M
Decreased by -246.67%
Decreased by -7.19%
Decreased by -239.68%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY